SYS-CON MEDIA Authors: Doug Masi, Mat Mathews, PR.com Newswire, David Smith, Tim Crawford

News Feed Item

New ISR Report Provides Insight Into CMO Service Quality, DSM Among the Top 3 in Each Attribute Category

Informing the Pharmaceutical Drug Development and Commercialization Industry

CARY, NC -- (Marketwired) -- 03/12/14 -- Industry Standard Research (ISR) today announced the availability of a new report titled "Contract Manufacturer Quality Benchmarking (2014)," providing a comprehensive assessment of CMO service quality.

"ISR has a long history of measuring service provider quality across the clinical development space and we are excited to broaden this offering to the pharmaceutical contract manufacturing industry," explained Andrew Schafer, ISR's President.

In this report, ISR provides pharmaceutical companies and contract manufacturing organizations a comprehensive analysis of current commercial outsourcing practices and trends and quantifies CMOs' service quality across a series of 27 performance attributes. ISR gathered data on 321 service encounters from senior-level decision-makers at pharmaceutical companies. Respondents were asked to provide their input on industry trends and rate their service experiences with CMOs they have used within the past 18 months. Respondents were given 27 performance attributes to rate, including: QA/ Audits, Meets regulatory requirements, Meets quality performance metrics, Cost effective, and many others.

Data includes analysis for 26 CMOs including: Aenova, Boehringer-Ingelheim GmbH, Cambridge Major, Catalent, Cedarburg Hauser Pharmaceuticals, Corden Pharma, DPT, DSM, Evonik, Famar, Fareva Holding, Haupt Pharma, Hospira, Jubilant Life Sciences, Lonza, LTS, NextPharma, NIPRO, Patheon, Pfizer Global Supply, Piramal Healthcare Ltd, Recipharm, Therapure Biopharma, UPM Pharmaceuticals, Vetter, and Xcelience.

Schafer continues, "As is the case within many of the industries and services ISR tracks, the service quality levels among and within pharmaceutical CMO providers varies quite a bit. CMOs profiled in this report can get a customer-based assessment of their quality. Pharma manufacturers can get peer-based assessment of the CMOs they may not have worked with and use this information to make better outsourcing decisions. There are several standout CMOs, however, only one, DSM, scored among the leaders across each of four attribute categories (Delivery, Organizational, Capabilities, and Staff characteristics)."

For more information on ISR's "Contract Manufacturer Quality Benchmarking (2014)" report, please visit ISR's report page at http://www.isrreports.com/product/2014-contract-manufacturer-quality-benchmarking/

For more information on ISR's other pharmaceutical service provider benchmarking reports, you may visit ISR's website at http://www.isrreports.com/product-category/cro-and-service-provider-benchmarking-reports/

About Industry Standard Research
Industry Standard Research is the premier, full service market research provider to the pharma and pharma services industries. With over a decade of experience, ISR delivers an unmatched level of domain expertise. For more information about ISR's off-the-shelf intelligence and custom research offerings, please visit the company's Web site at www.ISRreports.com, email [email protected], or follow ISR on Twitter @ISRreports.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2541273

Add to Digg Bookmark with del.icio.us Add to Newsvine

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.